AusBiotech 2018 Program

 
 

Call for session suggestions - closed

Help shape the program and submit a session proposal to be considered by the program committee.  Call for session suggestions have been extended from 31 January to 16 February 2018.

Click here to download the submission form.

 

Key topics

  • Regenerative medicine and its potential to provide solutions for previously untreatable conditions and diseases
  • Clinical trials, including strategies to help Australia maintain its competitive advantage and continue to attract international R&D
  • Drugs, vaccines, diagnostics and controls for tropical diseases
  • Key issues facing the global big pharma industry
  • Gene editing technologies
  • Fostering Australian innovation, with an update on the Innovation System Review
  • Big data and precision medicine
  • Australia's formulation development capabilities with regards to pre-clinical testing
  • Life science commercialisation and innovation
  • Managing R&D processes
  • Complementary medicines, examining academic collaborations and research outcomes
  • Agriculture and agbiotech
  • Intellectual property

The annual AusBiotech conference brings together Australian and international biotech leaders and stakeholders. For more than three decades, the event has created a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally.

AusBiotech is dedicated to consolidating this growth, and our 2018 conference will once again present issues critical to industry. Global biotech trends, breakthroughs, challenges and success stories will feature prominently on the program. Panel discussions and key themes will cover regulation and reimbursement, research translational strategies, new markets, business development and capital access, emerging technologies, clinical trials and commercialisation. 

 

Millis Orator - proudly supported by CSL

The Millis Oration is named after Emertius Professor Nancy Millis (1922-2012), the First Lady of biotechnology.

 

Early Stage Investment Event

One day investment event bringing world-leading biotech innovators together with Australia's early stage investment community to fund the future of life sciences.  Featuring a mix of expert keynotes and life sciences company presentations, the event merges market intelligence with investment opportunities and will encourage successful biotech investment.

 

Other features

  • BioIndustry Exhibition Hall
  • Satellite events
  • AusPartnering, AusBiotech’s highly recommended business matching program
  • Trade day

 

We gratefully acknowledge our session partners: